Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser
Start Date
4/16/2026
Completion Date
2/1/2027
Summary
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
Detailed Description
To compare procedure tolerability of the treated facial area between ariessence and standard aftercare (Aquaphor). Tolerability, using subject tolerability assessments (subject diaries), investigator tolerability assessments, and standardized day-3/7/14 photographs, with site confirmation.
Eligibility Criteria
Age Range: 40 years to 70 years
Interventions
ariessence pure PDGF+™ is a sterile aqueous formulation containing Hyaluronic Acid and pure platelet-derived growth factor (PDGF).
Conditions
Locations
Laser & Skin Surgery Medical Group
Sacramento, California 95816
United States
The Practice of Brian S. Biesman, MD
Nashville, Tennessee 37203
United States